• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Nationally Recognized Multiple Myeloma Expert Dr. David Vesole Joins the John Theurer Cancer Center at Hackensack University Medical Center

Posted on: Wednesday, 30 September 2009, 10:13 CDT

HACKENSACK, N.J., Sept. 30 /PRNewswire/ -- The John Theurer Cancer Center at Hackensack University Medical Center today proudly announced the addition of David H. Vesole, M.D., Ph.D., F.A.C.P. to its Multiple Myeloma Division. He will join division chief David S. Siegel, M.D., Ph.D., who has built a world-renowned myeloma clinical and research practice at the Cancer Center.

Dr. Vesole and Dr. Siegel are two of the foremost authorities in multiple myeloma, the second most prevalent form of blood cancer. They offer new and emerging therapies that enhance the quality and extend the lives of patients with multiple myeloma.

"Pairing up Dr. Vesole with Dr. Siegel creates a synergy of expertise that holds great promise to significantly improve the outcomes for patients with myeloma here at the Cancer Center and worldwide," says Andrew Pecora, M.D., F.A.C.P., chairman and executive administrative director of the John Theurer Cancer Center. "They both have a consistent track record of developing and leading state-of-the-art programs that translate directly into better patient care and longer survival for patients."

The John Theurer Cancer Center's Multiple Myeloma Division is one of only a few facilities in the U.S. to offer specialized expertise in the diagnosis, treatment, and management of multiple myeloma. Dr. Vesole will hold the position of co-division chief, myeloma, and director of research, myeloma division.

Dr. Vesole is an expert in stem cell transplant therapy for the treatment of multiple myeloma. He previously served as director of the bone marrow transplant program at Loyola University Chicago - Stritch School of Medicine. He has authored more than 120 articles in peer-reviewed medical journals and recently served as co-chair of the Eastern Cooperative Oncology Group Myeloma Committee and co-chair of the Center for International Blood and Marrow Transplant Research Plasma Cell Disorder Committee.

Dr. Siegel is a member of the International Myeloma Foundation's scientific advisory board and led the John Theurer Cancer Center's participation in the Multiple Myeloma Genomic Initiative, which involved the sharing of patient tissues across prominent hospitals. The initiative is designed to make clinical trials of new cancer drugs more efficient; the first wave of genome sequencing analysis will be released in coming months. Dr. Siegel's research has almost exclusively focused on multiple myeloma and has been published in many leading medical journals, including the British Journal of Haematology, the New England Journal of Medicine, Blood, and Bone Marrow Transplant.

John Theurer Cancer Center at Hackensack University Medical Center

The John Theurer Cancer Center at Hackensack University Medical Center is New Jersey's largest and most comprehensive center dedicated to the diagnosis, treatment, management, research, screenings, and preventive care as well as survivorship of patients with all types of cancer. The 15 specialized divisions covering the complete spectrum of cancer care have developed a close-knit team of medical, research, nursing, and support staff with specialized expertise that translates into more advanced, focused care for all patients. Each year, more people in the New Jersey/New York metropolitan area turn to the John Theurer Cancer Center for cancer care than to any other facility in New Jersey. Housed within a 775-bed, not-for-profit teaching, tertiary care, and research hospital, the John Theurer Cancer Center provides state-of-the-art technological advances, compassionate care, research innovations, medical expertise, and a full range of after care services that distinguish the John Theurer Cancer Center from other facilities.

SOURCE The John Theurer Cancer Center at Hackensack University Medical Center

Source: PR Newswire

More News in this Category